GenomeQuest, Inc. Release: GQ-Dx 2.0 Helps Laboratories Deliver Fast, Accurate, and Actionable NGS Diagnostics to the Clinic
2/23/2012 6:59:02 AM
WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest Inc., a global provider of large-scale genomic software applications, today introduced new enhancements to its GQ-Dx genomic decision support system that enables molecular laboratories to produce routine, actionable diagnostic reports from next generation sequencing (NGS) runs. Highlighted by a proprietary genomic knowledge engine, GQ-Dx 2.0 transforms NGS diagnostics from slow, labor-intensive odysseys into daily, healthcare operations. As a result, healthcare professionals can now offer this new generation of diagnostics to patients today.